Nura

Nura

Development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders.

Launch date
Market cap
-
Enterprise valuation
AUD59—88m (Dealroom.co estimates Sep 2004.)
Seattle Washington (HQ)
  • Edit
DateInvestorsAmountRound

$9.5m

Series A

N/A

Acquisition

N/A

Seed
Total FundingAUD14.7m

Recent News about Nura

Edit